These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 22996328)
1. TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma. Liu J; Liao S; Diop-Frimpong B; Chen W; Goel S; Naxerova K; Ancukiewicz M; Boucher Y; Jain RK; Xu L Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16618-23. PubMed ID: 22996328 [TBL] [Abstract][Full Text] [Related]
2. Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis. Ganapathy V; Ge R; Grazioli A; Xie W; Banach-Petrosky W; Kang Y; Lonning S; McPherson J; Yingling JM; Biswas S; Mundy GR; Reiss M Mol Cancer; 2010 May; 9():122. PubMed ID: 20504320 [TBL] [Abstract][Full Text] [Related]
3. An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer. Rausch MP; Hahn T; Ramanathapuram L; Bradley-Dunlop D; Mahadevan D; Mercado-Pimentel ME; Runyan RB; Besselsen DG; Zhang X; Cheung HK; Lee WC; Ling LE; Akporiaye ET Anticancer Res; 2009 Jun; 29(6):2099-109. PubMed ID: 19528470 [TBL] [Abstract][Full Text] [Related]
4. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines. Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis. Wendt MK; Schiemann WP Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433 [TBL] [Abstract][Full Text] [Related]
6. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition. Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560 [TBL] [Abstract][Full Text] [Related]
7. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. Yin JJ; Selander K; Chirgwin JM; Dallas M; Grubbs BG; Wieser R; Massagué J; Mundy GR; Guise TA J Clin Invest; 1999 Jan; 103(2):197-206. PubMed ID: 9916131 [TBL] [Abstract][Full Text] [Related]
8. The role of transforming growth factor-beta in suppression of hepatic metastasis from colon cancer. Are C; Simms N; Rajput A; Brattain M HPB (Oxford); 2010 Sep; 12(7):498-506. PubMed ID: 20815859 [TBL] [Abstract][Full Text] [Related]
9. LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells. Gao Y; Shan N; Zhao C; Wang Y; Xu F; Li J; Yu X; Gao L; Yi Z Int J Clin Exp Pathol; 2015; 8(5):4923-32. PubMed ID: 26191185 [TBL] [Abstract][Full Text] [Related]
10. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Takai K; Le A; Weaver VM; Werb Z Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor. Bandyopadhyay A; Agyin JK; Wang L; Tang Y; Lei X; Story BM; Cornell JE; Pollock BH; Mundy GR; Sun LZ Cancer Res; 2006 Jul; 66(13):6714-21. PubMed ID: 16818646 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo. Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621 [TBL] [Abstract][Full Text] [Related]
13. Exogenous introduction of tissue inhibitor of metalloproteinase 2 reduces accelerated growth of TGF-β-disrupted diffuse-type gastric carcinoma. Johansson E; Komuro A; Iwata C; Hagiwara A; Fuse Y; Watanabe A; Morishita Y; Aburatani H; Funa K; Kano MR; Miyazono K Cancer Sci; 2010 Nov; 101(11):2398-403. PubMed ID: 20718757 [TBL] [Abstract][Full Text] [Related]
14. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth. Micalizzi DS; Wang CA; Farabaugh SM; Schiemann WP; Ford HL Cancer Res; 2010 Dec; 70(24):10371-80. PubMed ID: 21056993 [TBL] [Abstract][Full Text] [Related]
15. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F; Lee J; Lu S; Pettaway CA; Dong Z Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft model. Drabsch Y; He S; Zhang L; Snaar-Jagalska BE; ten Dijke P Breast Cancer Res; 2013 Nov; 15(6):R106. PubMed ID: 24196484 [TBL] [Abstract][Full Text] [Related]